China · Delayed Price · Currency is CNY Novoray Statistics
Total Valuation
Novoray has a market cap or net worth of CNY 39.52 billion. The enterprise value is 39.05 billion.
| Market Cap | 39.52B |
| Enterprise Value | 39.05B |
Important Dates
The last earnings date was Saturday, August 15, 2026.
| Earnings Date | Aug 15, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
Novoray has 241.47 million shares outstanding. The number of shares has decreased by -0.44% in one year.
| Current Share Class | 241.47M |
| Shares Outstanding | 241.47M |
| Shares Change (YoY) | -0.44% |
| Shares Change (QoQ) | +4.61% |
| Owned by Insiders (%) | 40.83% |
| Owned by Institutions (%) | 10.96% |
| Float | 86.69M |
Valuation Ratios
The trailing PE ratio is 130.93 and the forward PE ratio is 88.72.
| PE Ratio | 130.93 |
| Forward PE | 88.72 |
| PS Ratio | 32.25 |
| PB Ratio | 22.13 |
| P/TBV Ratio | 23.15 |
| P/FCF Ratio | 277.80 |
| P/OCF Ratio | 145.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 99.38, with an EV/FCF ratio of 274.43.
| EV / Earnings | 128.86 |
| EV / Sales | 31.86 |
| EV / EBITDA | 99.38 |
| EV / EBIT | 119.30 |
| EV / FCF | 274.43 |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.42.
| Current Ratio | 4.88 |
| Quick Ratio | 4.45 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.93 |
| Debt / FCF | 5.33 |
| Interest Coverage | 50.40 |
Financial Efficiency
Return on equity (ROE) is 18.16% and return on invested capital (ROIC) is 22.38%.
| Return on Equity (ROE) | 18.16% |
| Return on Assets (ROA) | 8.30% |
| Return on Invested Capital (ROIC) | 22.38% |
| Return on Capital Employed (ROCE) | 12.72% |
| Weighted Average Cost of Capital (WACC) | 11.44% |
| Revenue Per Employee | 1.49M |
| Profits Per Employee | 369,530 |
| Employee Count | 785 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 5.39 |
Taxes
In the past 12 months, Novoray has paid 43.62 million in taxes.
| Income Tax | 43.62M |
| Effective Tax Rate | 12.58% |
Stock Price Statistics
The stock price has increased by +209.71% in the last 52 weeks. The beta is 1.34, so Novoray's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +209.71% |
| 50-Day Moving Average | 159.27 |
| 200-Day Moving Average | 111.22 |
| Relative Strength Index (RSI) | 51.43 |
| Average Volume (20 Days) | 15,937,710 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novoray had revenue of CNY 1.23 billion and earned 303.01 million in profits. Earnings per share was 1.25.
| Revenue | 1.23B |
| Gross Profit | 478.47M |
| Operating Income | 327.28M |
| Pretax Income | 346.63M |
| Net Income | 303.01M |
| EBITDA | 390.10M |
| EBIT | 327.28M |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 1.24 billion in cash and 758.64 million in debt, with a net cash position of 478.51 million or 1.98 per share.
| Cash & Cash Equivalents | 1.24B |
| Total Debt | 758.64M |
| Net Cash | 478.51M |
| Net Cash Per Share | 1.98 |
| Equity (Book Value) | 1.79B |
| Book Value Per Share | 7.40 |
| Working Capital | 1.52B |
Cash Flow
In the last 12 months, operating cash flow was 270.74 million and capital expenditures -128.46 million, giving a free cash flow of 142.28 million.
| Operating Cash Flow | 270.74M |
| Capital Expenditures | -128.46M |
| Depreciation & Amortization | 62.82M |
| Net Borrowing | 712.25M |
| Free Cash Flow | 142.28M |
| FCF Per Share | 0.59 |
Margins
Gross margin is 39.04%, with operating and profit margins of 26.70% and 24.72%.
| Gross Margin | 39.04% |
| Operating Margin | 26.70% |
| Pretax Margin | 28.28% |
| Profit Margin | 24.72% |
| EBITDA Margin | 31.83% |
| EBIT Margin | 26.70% |
| FCF Margin | 11.61% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 39.88% |
| Buyback Yield | 0.44% |
| Shareholder Yield | 0.73% |
| Earnings Yield | 0.77% |
| FCF Yield | 0.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Novoray is 151.00, which is -7.75% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | 151.00 |
| Price Target Difference | -7.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 31.68% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 29, 2025. It was a forward split with a ratio of 1.3.
| Last Split Date | May 29, 2025 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
Novoray has an Altman Z-Score of 11.94 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.94 |
| Piotroski F-Score | 4 |